MacroGenics, Inc.
General ticker "MGNX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $129.3M (TTM average)
MacroGenics, Inc. follows the US Stock Market performance with the rate: 11.7%.
Estimated limits based on current volatility of 3.1%: low 1.38$, high 1.47$
Factors to consider:
- Total employees count: 339 (-5.0%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Clinical development risks, Manufacturing risks, Public health crises, Patent risks, Cybersecurity threats
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.53$, 4.11$]
- 2025-12-31 to 2026-12-31 estimated range: [1.48$, 3.90$]
Financial Metrics affecting the MGNX estimates:
- Positive: with PPE of -3.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -33.85 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 44.35 <= 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 73.91 > -0.66
Short-term MGNX quotes
Long-term MGNX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $151.94MM | $58.75MM | $149.96MM |
| Operating Expenses | $273.36MM | $226.99MM | $260.54MM |
| Operating Income | $-121.42MM | $-168.24MM | $-110.58MM |
| Non-Operating Income | $1.66MM | $159.19MM | $44.56MM |
| Interest Expense | $0.00MM | $1.43MM | $1.11MM |
| R&D Expense | $207.03MM | $166.58MM | $177.19MM |
| Income(Loss) | $-119.76MM | $-9.06MM | $-66.02MM |
| Taxes | $0.00MM | $0.00MM | $0.94MM |
| Profit(Loss)* | $-119.76MM | $-9.06MM | $-66.97MM |
| Stockholders Equity | $142.01MM | $152.61MM | $116.06MM |
| Inventory | $1.45MM | $1.22MM | $0.00MM |
| Assets | $280.47MM | $298.42MM | $261.65MM |
| Operating Cash Flow | $-86.96MM | $-78.20MM | $-68.37MM |
| Capital expenditure | $3.62MM | $1.76MM | $3.71MM |
| Investing Cash Flow | $70.72MM | $-80.08MM | $149.30MM |
| Financing Cash Flow | $1.66MM | $150.36MM | $0.96MM |
| Earnings Per Share** | $-1.95 | $-0.15 | $-1.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.